CannPal Animal Therapeutics, a Sydney-based pharmaceutical technology startup, is looking to raise A$6 million ($4.74 million) in its initial public offer (IPO) on the Australian Securities Exchange (ASX) slated for October 2017.
Continue reading this story with a subscription to DealStreetAsia.
Already a subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com.
